AR030309A1 - Composicion farmaceutica - Google Patents
Composicion farmaceuticaInfo
- Publication number
- AR030309A1 AR030309A1 ARP010103708A ARP010103708A AR030309A1 AR 030309 A1 AR030309 A1 AR 030309A1 AR P010103708 A ARP010103708 A AR P010103708A AR P010103708 A ARP010103708 A AR P010103708A AR 030309 A1 AR030309 A1 AR 030309A1
- Authority
- AR
- Argentina
- Prior art keywords
- pharmaceutical composition
- phenoxyalkyl
- thiazolidinedione
- metformin
- optionally
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/12—Antidiuretics, e.g. drugs for diabetes insipidus
Landscapes
- Health & Medical Sciences (AREA)
- Diabetes (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Hematology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Endocrinology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Composicion farmacéutica que comprende, como ingredientes activos, metformina, opcionalmente bajo la forma de una de sus sales aceptables para el uso farmacéutico, y un derivado tipo 5-fenoxialquil 2, 4-tiazolidindiona.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0010362A FR2812547B1 (fr) | 2000-08-04 | 2000-08-04 | Composition pharmaceutique comprenant une association metformine et derive de thiazolidinedione et son utilisation pour la preparation de medicaments destines a traiter le diabete |
Publications (1)
Publication Number | Publication Date |
---|---|
AR030309A1 true AR030309A1 (es) | 2003-08-20 |
Family
ID=8853342
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP010103708A AR030309A1 (es) | 2000-08-04 | 2001-08-03 | Composicion farmaceutica |
Country Status (19)
Country | Link |
---|---|
US (1) | US20040014797A1 (es) |
EP (1) | EP1305025A1 (es) |
JP (1) | JP2004505915A (es) |
KR (1) | KR20030019470A (es) |
CN (1) | CN1446090A (es) |
AR (1) | AR030309A1 (es) |
AU (1) | AU2001282010A1 (es) |
BR (1) | BR0112915A (es) |
CA (1) | CA2417883A1 (es) |
CZ (1) | CZ2003476A3 (es) |
EC (1) | ECSP034463A (es) |
FR (1) | FR2812547B1 (es) |
HU (1) | HUP0303684A2 (es) |
MX (1) | MXPA03000975A (es) |
NO (1) | NO20030518L (es) |
PL (1) | PL358791A1 (es) |
RU (1) | RU2003105809A (es) |
SK (1) | SK2082003A3 (es) |
WO (1) | WO2002011721A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8911781B2 (en) | 2002-06-17 | 2014-12-16 | Inventia Healthcare Private Limited | Process of manufacture of novel drug delivery system: multilayer tablet composition of thiazolidinedione and biguanides |
UA80991C2 (en) * | 2002-10-07 | 2007-11-26 | Solid preparation containing an insulin resistance improving drug and an active ingredient useful as a remedy for diabetes | |
WO2008016729A1 (en) * | 2006-08-04 | 2008-02-07 | Nastech Pharmaceutical Company Inc. | Compositions for intranasal delivery of human insulin and uses thereof |
US8058312B2 (en) | 2007-01-29 | 2011-11-15 | Hanall Biopharma Co., Ltd. | N, N-dimethyl imidodicarbonimidic diamide acetate, method for producing the same and pharmaceutical compositions comprising the same |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2749583B1 (fr) * | 1996-06-07 | 1998-08-21 | Lipha | Nouveaux derives de thiazolidine -2,4- dione substitues, leurs procedes d'obtention et les compositions pharmaceutiques en renfermant |
KR20060105005A (ko) * | 1997-06-18 | 2006-10-09 | 스미스클라인비이참피이엘시이 | 티아졸리딘디온 및 메트포르민을 사용한 당뇨병의 치료 |
GB9715295D0 (en) * | 1997-07-18 | 1997-09-24 | Smithkline Beecham Plc | Novel method of treatment |
-
2000
- 2000-08-04 FR FR0010362A patent/FR2812547B1/fr not_active Expired - Fee Related
-
2001
- 2001-07-24 SK SK208-2003A patent/SK2082003A3/sk unknown
- 2001-07-24 BR BR0112915-5A patent/BR0112915A/pt not_active Application Discontinuation
- 2001-07-24 JP JP2002517057A patent/JP2004505915A/ja active Pending
- 2001-07-24 MX MXPA03000975A patent/MXPA03000975A/es unknown
- 2001-07-24 CZ CZ2003476A patent/CZ2003476A3/cs unknown
- 2001-07-24 US US10/343,609 patent/US20040014797A1/en not_active Abandoned
- 2001-07-24 AU AU2001282010A patent/AU2001282010A1/en not_active Abandoned
- 2001-07-24 CN CN01813685A patent/CN1446090A/zh active Pending
- 2001-07-24 KR KR1020027018026A patent/KR20030019470A/ko not_active Application Discontinuation
- 2001-07-24 EP EP01960539A patent/EP1305025A1/en not_active Withdrawn
- 2001-07-24 CA CA002417883A patent/CA2417883A1/en not_active Abandoned
- 2001-07-24 PL PL01358791A patent/PL358791A1/xx unknown
- 2001-07-24 WO PCT/EP2001/008512 patent/WO2002011721A1/en not_active Application Discontinuation
- 2001-07-24 HU HU0303684A patent/HUP0303684A2/hu unknown
- 2001-07-24 RU RU2003105809/15A patent/RU2003105809A/ru not_active Application Discontinuation
- 2001-08-03 AR ARP010103708A patent/AR030309A1/es unknown
-
2003
- 2003-02-03 NO NO20030518A patent/NO20030518L/no not_active Application Discontinuation
- 2003-02-03 EC EC2003004463A patent/ECSP034463A/es unknown
Also Published As
Publication number | Publication date |
---|---|
KR20030019470A (ko) | 2003-03-06 |
CZ2003476A3 (cs) | 2003-06-18 |
SK2082003A3 (en) | 2003-07-01 |
BR0112915A (pt) | 2003-07-08 |
CA2417883A1 (en) | 2002-02-14 |
FR2812547A1 (fr) | 2002-02-08 |
JP2004505915A (ja) | 2004-02-26 |
NO20030518D0 (no) | 2003-02-03 |
US20040014797A1 (en) | 2004-01-22 |
RU2003105809A (ru) | 2004-08-27 |
FR2812547B1 (fr) | 2002-10-31 |
MXPA03000975A (es) | 2003-06-09 |
EP1305025A1 (en) | 2003-05-02 |
PL358791A1 (en) | 2004-08-23 |
CN1446090A (zh) | 2003-10-01 |
NO20030518L (no) | 2003-02-03 |
HUP0303684A2 (hu) | 2004-03-01 |
WO2002011721A1 (en) | 2002-02-14 |
AU2001282010A1 (en) | 2002-02-18 |
ECSP034463A (es) | 2003-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ECSP034774A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
ECSP034773A (es) | Pirazolopirimmidinas como agentes terapeuticos | |
ES2162517T3 (es) | Composicion farmaceutica que comprende una combinacion de metformin y fibrato y su uso en la preparacion de medicamentos destinados a reducir la hiperglicemia. | |
PA8539901A1 (es) | Novedosa sal de succinato de o-desmetil-venlafaxina | |
ES2581331T3 (es) | Inhibidor de la progresión de una enfermedad atribuida a una acumulación anormal de grasa hepática | |
ECSP045491A (es) | Nueva sal formiato de o-desmetil venlafaxina | |
ECSP055853A (es) | Nuevos derivados de fluoroglicosidos heterociclicos, productos farmaceuticos que contienen dichos compuestos, y el uso de los mismos | |
AR037407A1 (es) | Composiciones farmaceuticas para el tratamiento de la diabetes mellitus de tipo ii | |
HN2002000275A (es) | Derivados de 1,8 naftiridina y su uso para el tratamiento de diabetes y trastornos relacionados | |
PA8518801A1 (es) | Derivados de 2-aminocarbonil-9h-purina | |
RS50510B (sr) | Formulacije koje sadrže ekteinascidin i disaharid | |
AR058433A1 (es) | Derivado de 1,1-dioxido de 1,4-benzotiazepina ,procedimiento para su preparacion ,medicamentos que comprenden este compuesto y su uso | |
ECSP077999A (es) | Formulaciones de una sal de bupropion de liberación modificada | |
UY25242A1 (es) | Inhibidores de benzotiazol de la proteína tirosina cinasa | |
ECSP066481A (es) | Formulaciones que contienen cobre | |
ES2421948T3 (es) | Compuestos y composiciones para suministrar agentes activos | |
HN2003000183A (es) | Difenilazetidinonas sustituidas en anillo procedimiento para su preparacion, medicamentos que comprenden estos compuestos y su uso. | |
AR057928A1 (es) | Composiciones farmaeuticas de azd 2171 | |
CO6321285A2 (es) | Uso de 3,11b-cis- dihidrotetrabenazina en el tratamiento de la esclerosis multiple y la mielitis autoinmunitaria | |
AR041339A1 (es) | Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen | |
AR031649A1 (es) | Composicion farmaceutica de dronedarona para administracion parenteral | |
ITRM20030363A0 (it) | Composizioni comprendenti la 3, 5diiodotironina e uso farmaceutico diesse. | |
AR030309A1 (es) | Composicion farmaceutica | |
UY28461A1 (es) | Composición nueva | |
CO5550418A2 (es) | Formulaciones antihistaminicas para formas de dosificacion de capsula blanda |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |